Navigation Links
Salk Welcomes National Leader in Academic Technology Transfer
Date:3/4/2011

LA JOLLA, Calif., March 4, 2011 /PRNewswire-USNewswire/ -- The Salk Institute is pleased to announce the appointment of Robert MacWright, Ph.D., Esq. as Executive Director of the Salk Institute Office of Technology Development. His appointment begins February 14, 2011.

Dr. MacWright has extensive experience in academic technology transfer.  For over a decade he was Executive Director of the University of Virginia Patent Foundation, where he led a broad expansion and modernization of its patent and licensing activities. He also led the creation of a subsidiary that supported faculty start-up companies, and the creation of a local angel investment fund.  He previously led the creation and development of technology transfer programs at Rutgers University, and served as Executive Director of the Rutgers University Office of Corporate Liaison and Technology Transfer.

"Robert's strategic and academic experience will be a huge asset to the Salk," said William R. Brody, President, Salk Institute.  "His deep understanding of basic research, academia and industry is unique and he is poised to take our Technology Transfer to new heights."

Dr. MacWright brings expertise as a patent lawyer, having practiced law at Kenyon & Kenyon, at Skadden, Arps, Slate Meagher & Flom, and at Frommer Lawrence & Haug.  He holds a Ph.D. in biochemistry from Rutgers University and the University of Medicine & Dentistry of New Jersey.  He has academic and industry research experience in protein chemistry and molecular genetics. He holds a law degree from The Rutgers School of Law in Newark.

"The Office of Technology Management and Development plays a significant role in Salk's ability to advance basic research into the marketplace.  Robert's energy and advocacy come at a crucial time. We look forward to his leadership," said Marsha Chandler, Executive Vice President, Salk Institute.

About the Salk Institute for Biological Studies:

The Salk Institute for Biological Studies is one of the world's preeminent basic research institutions, where internationally renowned faculty probe fundamental life science questions in a unique, collaborative, and creative environment. Focused both on discovery and on mentoring future generations of researchers, Salk scientists make groundbreaking contributions to our understanding of cancer, aging, Alzheimer's, diabetes and infectious diseases by studying neuroscience, genetics, cell and plant biology, and related disciplines.

Faculty achievements have been recognized with numerous honors, including Nobel Prizes and memberships in the National Academy of Sciences. Founded in 1960 by polio vaccine pioneer Jonas Salk, M.D., the Institute is an independent nonprofit organization and architectural landmark.Media Contacts:Kat Kearney858-453-4100x1226kkearney@salk.eduThis news release was issued on behalf of Newswise(TM).  For more information, visit http://www.newswise.com.


'/>"/>
SOURCE Salk Institute for Biological Studies
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Trusted LASIK Surgeons Welcomes Dallas LASIK Eye Surgery Specialist Dr. R. Wayne Bowman to its LASIK Directory
2. Association of Clinical Research Organizations (ACRO) Welcomes Clinilabs and RPS as New Members
3. Trusted LASIK Surgeons Welcomes Mobile Alabama Expert Refractive Eye Surgeon Richard Duffey, M.D. to Its LASIK Directory For Consumers
4. Desert Radiologists Welcomes Five New Physicians to the Practice
5. Trusted LASIK Surgeons Welcomes Leading LASIK Eye Surgery Expert, Inventor David Huang, M.D., Los Angeles, to Its Unique Lasik Directory Service
6. Sound Surgical Technologies Welcomes Dr. Mark Schafer as New Chief Technology Officer and Vice President of Research & Development
7. Spring Point Project Welcomes Second Generation Medical-Grade Piglets
8. Vineland Welcomes Dr. Daryl Somers as Research Chair, Molecular Breeding and Biotechnology
9. Sigma-Aldrich Welcomes Memorial Sloan-Kettering Cancer Center to the RNAi Partnership Program
10. Vineland Welcomes Dr. Isabelle Lesschaeve as Research Chair, Sensory and Consumer Sciences
11. South Africas Minister of Minerals and Energy Welcomes Denham Capital Investment in BioTherm Energy to Develop Power Generation Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... Calif. , Oct. 10, 2017 SomaGenics ... from the NIH to develop RealSeq®-SC (Single Cell), expected ... for profiling small RNAs (including microRNAs) from single cells ... Program highlights the need to accelerate development of approaches ... "New techniques for measuring levels ...
(Date:10/9/2017)... , ... October 09, 2017 , ... The award-winning American ... broadcast first quarter 2018. American Farmer airs Tuesdays at 8:30aET on RFD-TV. , ... faced with the challenge of how to continue to feed a growing nation. At ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... and applications consulting for microscopy and surface analysis, Nanoscience Instruments is now ... Analytical offers a broad range of contract analysis services for advanced applications. ...
(Date:10/6/2017)... ... 06, 2017 , ... On Tuesday, October 24th, ABC² (Accelerate ... first-ever adaptive clinical trial for glioblastoma (GBM). The featured speaker will be Dr. ... open to the public, but registration is required. , WHAT: ABC² Brain ...
Breaking Biology Technology:
(Date:4/5/2017)... Allen Institute for Cell Science today announces the launch ... dynamic digital window into the human cell. The website ... deep learning to create predictive models of cell organization, ... suite of powerful tools. The Allen Cell Explorer will ... resources created and shared by the Allen Institute for ...
(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
Breaking Biology News(10 mins):